Gemcitabine and Oxaliplatin in Patients With Pancreatic Adenocarcinoma
Mario Airoldi, Claudio Zanon, Luigi Cattel(University of Turin), Fulvia Pedani(Ospedale San Giovanni Antica Sede), Paola Milla(University of Turin), Roberto Passera(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino)
Cited by 12
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k